Oyku Cerit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oyku Cerit has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Anjanet Loon
Picower Institute for Learning and Memory, Massachusetts Institute of Technology Cambridge Massachusetts USA
1 shared publicationBlerta Milo
Picower Institute for Learning and Memory, Massachusetts Institute of Technology Cambridge Massachusetts USA
1 shared publication- Hannah Woolf
Picower Institute for Learning and Memory, Massachusetts Institute of Technology Cambridge Massachusetts USA
1 shared publication - Jay Penney
Department of Biomedical Sciences, AVC, University of Prince Edward Island, Charlottetown, Canada
1 shared publication - Li-Huei Tsai
Broad Institute of MIT and Harvard, Cambridge, MA, USA
1 shared publication - Ping-Chieh Pao
Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, USA
1 shared publication
Latest Publications
- Open Access
iPSC‐derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss
Genetic findings have highlighted key roles for microglia in the pathology of neurodegenerative conditions such as Alzheimer's disease (AD). A number of mutations in the microglial protein triggering receptor expressed on myeloid cells 2 (TREM2) have been associated with increased risk for developing AD, most notably the R47H/+ substitution. We employed gene editing and stem cell models to gain insight into the effects of the TREM2 R47H/+ mutation on human‐induced pluripotent stem cell‐derived microglia. We found transcriptional changes affecting numerous cellular processes, with R47H/+ cells exhibiting a proinflammatory gene expression signature. TREM2 R47H/+ also caused impairments in microglial movement and the uptake of multiple substrates, as well as rendering microglia hyperresponsive to inflammatory stimuli. We developed an in vitro laser‐induced injury model in neuron–microglia cocultures, finding an impaired injury response by TREM2 R47H/+ microglia. Furthermore, mouse brains transplanted with TREM2 R47H/+ microglia exhibited reduced synaptic density, with upregulation of multiple complement cascade components in TREM2 R47H/+ microglia suggesting inappropriate synaptic pruning as one potential mechanism. These findings identify a number of potentially detrimental effects of the TREM2 R47H/+ mutation on microglial gene expression and function likely to underlie its association with AD.
Open AccessiPSC‐derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss
Genetic findings have highlighted key roles for microglia in the pathology of neurodegenerative conditions such as Alzheimer's disease (AD). A number of mutations in the microglial protein triggering receptor expressed on myeloid cells 2 (TREM2) have been associated with increased risk for developing AD, most notably the R47H/+ substitution. We employed gene editing and stem cell models to gain insight into the effects of the TREM2 R47H/+ mutation on human‐induced pluripotent stem cell‐derived microglia. We found transcriptional changes affecting numerous cellular processes, with R47H/+ cells exhibiting a proinflammatory gene expression signature. TREM2 R47H/+ also caused impairments in microglial movement and the uptake of multiple substrates, as well as rendering microglia hyperresponsive to inflammatory stimuli. We developed an in vitro laser‐induced injury model in neuron–microglia cocultures, finding an impaired injury response by TREM2 R47H/+ microglia. Furthermore, mouse brains transplanted with TREM2 R47H/+ microglia exhibited reduced synaptic density, with upregulation of multiple complement cascade components in TREM2 R47H/+ microglia suggesting inappropriate synaptic pruning as one potential mechanism. These findings identify a number of potentially detrimental effects of the TREM2 R47H/+ mutation on microglial gene expression and function likely to underlie its association with AD.